Literature DB >> 23012657

The tumor suppressor PTEN is exported in exosomes and has phosphatase activity in recipient cells.

Ulrich Putz1, Jason Howitt, Anh Doan, Choo-Peng Goh, Ley-Hian Low, John Silke, Seong-Seng Tan.   

Abstract

Exosomes are microvesicles of endosomal origin that are secreted, and their contents (proteins, lipids, DNA, or microRNAs) can alter the physiological states of recipient cells. We demonstrated that phosphatase and tensin homolog deleted on chromosome 10 (PTEN), a tumor suppressor protein normally localized in the cytoplasm and nucleus, was secreted in exosomes. Secreted PTEN was internalized by recipient cells with resultant functional activity, which resulted in reduced phosphorylation of the serine and threonine kinase Akt and reduced cellular proliferation. PTEN secretion in exosomes required Ndfip1, an adaptor protein for members of the Nedd4 family of E3 ubiquitin ligases. Without Ndfip1, neither Nedd4-1 nor Nedd4-2 promoted the recruitment of PTEN into exosomes. In addition, lysine 13 within PTEN, which is required for its ubiquitination by Nedd4-1, was required for exosomal transport of PTEN. These results implicate Ndfip1 as a molecular regulator of the exosomal export of PTEN, with consequences for non-cell-autonomous PTEN activity. Thus, we suggest that the ability of PTEN to exert phosphatase activity beyond the cell in which it is produced has implications for PTEN function during development, health, and disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23012657     DOI: 10.1126/scisignal.2003084

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  135 in total

Review 1.  Molecular pathways: intercellular PTEN and the potential of PTEN restoration therapy.

Authors:  Benjamin D Hopkins; Ramon E Parsons
Journal:  Clin Cancer Res       Date:  2014-11-01       Impact factor: 12.531

Review 2.  Tumor-derived exosomes in oncogenic reprogramming and cancer progression.

Authors:  Sarmad N Saleem; Asim B Abdel-Mageed
Journal:  Cell Mol Life Sci       Date:  2014-08-26       Impact factor: 9.261

3.  Inhibition of oncogenic epidermal growth factor receptor kinase triggers release of exosome-like extracellular vesicles and impacts their phosphoprotein and DNA content.

Authors:  Laura Montermini; Brian Meehan; Delphine Garnier; Wan Jin Lee; Tae Hoon Lee; Abhijit Guha; Khalid Al-Nedawi; Janusz Rak
Journal:  J Biol Chem       Date:  2015-08-13       Impact factor: 5.157

4.  Therapeutic targeting of cancers with loss of PTEN function.

Authors:  Lloye M Dillon; Todd W Miller
Journal:  Curr Drug Targets       Date:  2014-01       Impact factor: 3.465

5.  Pills of PTEN? In and out for tumor suppression.

Authors:  Antonella Papa; Ming Chen; Pier Paolo Pandolfi
Journal:  Cell Res       Date:  2013-08-06       Impact factor: 25.617

Review 6.  PTEN function: the long and the short of it.

Authors:  Benjamin D Hopkins; Cindy Hodakoski; Douglas Barrows; Sarah M Mense; Ramon E Parsons
Journal:  Trends Biochem Sci       Date:  2014-03-18       Impact factor: 13.807

Review 7.  Regulation and modulation of PTEN activity.

Authors:  Elahe Naderali; Amir Afshin Khaki; Jafar Soleymani Rad; Alireza Ali-Hemmati; Mohammad Rahmati; Hojjatollah Nozad Charoudeh
Journal:  Mol Biol Rep       Date:  2018-08-25       Impact factor: 2.316

8.  Molecular pathways: tumor-derived microvesicles and their interactions with immune cells in vivo.

Authors:  Ferdinando Pucci; Mikael J Pittet
Journal:  Clin Cancer Res       Date:  2013-02-20       Impact factor: 12.531

9.  Ionizing radiation and glioblastoma exosomes: implications in tumor biology and cell migration.

Authors:  W Tris Arscott; Anita T Tandle; Shuping Zhao; Jacob E Shabason; Ira K Gordon; Cody D Schlaff; Guofeng Zhang; Philip J Tofilon; Kevin A Camphausen
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

Review 10.  The potential of tumor-derived exosomes for noninvasive cancer monitoring.

Authors:  Theresa L Whiteside
Journal:  Expert Rev Mol Diagn       Date:  2015-08-02       Impact factor: 5.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.